Conn. Agencies Regs. § 21a-408-69 - Marijuana advertising; requirements for true statements and fair balance
(a) All advertisements for marijuana or
marijuana products that make a statement relating to side effects,
consequences, contraindications and effectiveness shall present a true
statement of such information. When applicable, advertisements broadcast
through media such as radio, television, or other electronic media shall
include such information in the audio or audio and visual parts of the
presentation.
(b) False or
misleading information in any part of the advertisement shall not be corrected
by the inclusion of a true statement in another distinct part of the
advertisement.
(c) An advertisement
does not satisfy the requirement that it present a "true statement" of
information relating to side effects, consequences, contraindications, and
effectiveness if it fails to present a fair balance between information
relating to side effects, consequences, contraindications and effectiveness in
that the information relating to effectiveness is presented in greater scope,
depth, or detail than is the information relating to side effects, consequences
and contraindications, taking into account all implementing factors such as
typography, layout, contrast, headlines, paragraphing, white space, and any
other techniques apt to achieve emphasis.
(d) An advertisement is false, lacking in
fair balance, or otherwise misleading if it:
(1) Contains a representation or suggestion
that a marijuana strain, brand or product is better, more effective, useful in
a broader range of conditions or patients or safer than other drugs or
treatments including other marijuana strains or products, unless such a claim
has been demonstrated by substantial evidence or substantial clinical
experience;
(2) Contains favorable
information or opinions about a marijuana product previously regarded as valid
but which have been rendered invalid by contrary and more credible recent
information;
(3) Uses a quote or
paraphrase out of context or without citing conflicting information from the
same source, to convey a false or misleading idea;
(4) Uses a study on individuals without a
debilitating medical condition without disclosing that the subjects were not
suffering from a debilitating medical condition;
(5) Uses data favorable to a marijuana
product derived from patients treated with a different product or dosages
different from those approved in the state of Connecticut;
(6) Contains favorable information or
conclusions from a study that is inadequate in design, scope, or conduct to
furnish significant support for such information or conclusions; or
(7) Fails to provide adequate emphasis for
the fact that two or more facing pages are part of the same advertisement when
only one page contains information relating to side effects, consequences and
contraindications.
(e) No
advertisement may be disseminated if the submitter of the advertisement has
received information that has not been widely publicized in medical literature
that the use of the marijuana product or strain may cause fatalities or serious
damage to a patient.
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.